Then, we further tested the SLC31A1 protein expression level by using data from the CPTAC database (N = 10, T = 100), and we found that the SLC31A1 protein is upmodulated in glioma samples (p = 0.0205) (Fig. 1C). Here, SLC31A1 is linked to central nervous system cancer.